文献速递腹部泌尿生殖MR

常染色体显性多囊肾病中的脾脏表型

Spleen phenotype in autosomal dominant polycystic kidney disease.
PubMed 文献 · Clin Radiol · 2019-09-25

本研究评估常染色体显性多囊肾病(ADPKD)患者脾脏表型,包括脾囊肿和脾大是否与ADPKD相关。结果显示ADPKD患者与对照组的T2高信号脾脏病灶患病率相似(7% vs 5%,p=0.32),但ADPKD患者脾脏体积中位数显著高于对照组(236 vs 176 ml,p<0.0001),且身高校正脾脏体积与身高校正总肾脏体积直接相关,提示脾大可能与ADPKD发病机制有关。

要点

  • ADPKD患者T2高信号脾脏病灶患病率与对照组无显著差异(7% vs 5%,p=0.32)。
  • ADPKD患者脾脏体积中位数显著高于对照组(236 vs 176 ml,p<0.0001)。
  • 身高校正脾脏体积与身高校正总肾脏体积直接相关,提示脾大可能与ADPKD严重程度相关。

核心结论

  • T2高信号脾脏病灶在ADPKD患者与非ADPKD对照组中患病率相似,提示与ADPKD诊断无关;但ADPKD患者脾大不能由肝脏囊性受累、感染/炎症或出血性肾囊肿解释,且身高校正脾脏体积与身高校正总肾脏体积直接相关,提示脾大可能与ADPKD发病机制有关。

研究设计与样本

  • 研究纳入ADPKD患者215例和年龄/性别匹配的对照215例,由三名盲法观察者评估轴位/冠状位T2加权图像上T2高信号脾脏病灶,并评估脾脏体积与临床、影像特征及PKD1/PKD2基因检测结果的关系。

关键影像表现/征象

  • T2高信号脾脏病灶在ADPKD患者中16/215(7%),对照组中11/215(5%),p=0.32。
  • T2高信号脾脏病灶在PKD1或PKD2突变患者中患病率相似。
  • ADPKD患者脾脏体积中位数236(182; 313 ml)vs 对照组176(129; 264 ml),p<0.0001。

诊断标准与关键数值

  • T2高信号脾脏病灶定义为T2加权图像上脾脏内高信号病灶。
  • 脾脏体积中位数ADPKD组236(182; 313 ml)vs 对照组176(129; 264 ml),p<0.0001。
  • 多变量分析中身高校正脾脏体积与身高校正总肾脏体积直接相关。

临床应用与阅片要点

  • 阅片时应注意ADPKD患者T2高信号脾脏病灶与对照组患病率相似,可能为无关偶发发现。
  • ADPKD患者脾脏体积增大,且与身高校正总肾脏体积相关,报告时可关注脾脏体积。
  • 脾大不能由肝脏囊性受累、感染/炎症或出血性肾囊肿解释。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate splenic phenotype in autosomal dominant polycystic kidney disease (ADPKD) including presence of cysts and splenomegaly to determine if these are ADPKD related or represent unrelated incidental findings.

MATERIALS AND METHODS: The axial/coronal T2-weighted images of ADPKD patients (n=215) and age/gender-matched controls (n=215) were evaluated for the presence of T2-bright splenic lesions by three blinded observers. Spleen volume (SV) was evaluated in the context of clinical and imaging features as well as results of gene testing for PKD1 and PKD2 mutations.

RESULTS: T2-bright splenic lesions were found in 16 of 215 (7%) ADPKD patients compared to 11 of 215 (5%) control patients (p=0.32) and their prevalence was similar in patients with either PKD1 or PKD2 mutations. Median SV was significantly higher in ADPKD patients than controls (236 [182; 313 ml] versus 176 [129; 264 ml], p<0.0001). In multivariable analysis, height-adjusted SV (htSV) was not associated with the presence of liver cysts, haemorrhagic cysts, or infections; however, htSV was directly associated with height-adjusted total kidney volume (htTKV), a biomarker for ADPKD disease severity.

CONCLUSIONS: The prevalence of T2-bright splenic lesions is similar in ADPKD patients and non-ADPKD controls, suggesting no relation to the diagnosis of ADPKD; however, splenic enlargement in ADPKD compared to controls could not be explained by liver cystic involvement, by infection/inflammatory conditions, or by haemorrhagic renal cysts. This combined with direct correlation of htSV with htTKV, a biomarker of ADPKD severity, suggests splenomegaly may be related to the pathogenesis of ADPKD.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yin X, Prince WK, Blumenfeld JD, et al. Spleen phenotype in autosomal dominant polycystic kidney disease. Clin Radiol. 2019. PMID: 31563290. doi:10.1016/j.crad.2019.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。